ES453263A1 - Procedimiento para preparar derivados de la guanidina anta- gonistas de histamina h2. - Google Patents

Procedimiento para preparar derivados de la guanidina anta- gonistas de histamina h2.

Info

Publication number
ES453263A1
ES453263A1 ES453263A ES453263A ES453263A1 ES 453263 A1 ES453263 A1 ES 453263A1 ES 453263 A ES453263 A ES 453263A ES 453263 A ES453263 A ES 453263A ES 453263 A1 ES453263 A1 ES 453263A1
Authority
ES
Spain
Prior art keywords
histamine
antagonists
compounds
useful
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES453263A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Publication of ES453263A1 publication Critical patent/ES453263A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES453263A 1975-11-12 1976-11-12 Procedimiento para preparar derivados de la guanidina anta- gonistas de histamina h2. Expired ES453263A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB46732/75A GB1573611A (en) 1975-11-12 1975-11-12 Heterocyclic thioalkyl-amines-guanidines and -thioureas

Publications (1)

Publication Number Publication Date
ES453263A1 true ES453263A1 (es) 1978-01-16

Family

ID=10442384

Family Applications (1)

Application Number Title Priority Date Filing Date
ES453263A Expired ES453263A1 (es) 1975-11-12 1976-11-12 Procedimiento para preparar derivados de la guanidina anta- gonistas de histamina h2.

Country Status (22)

Country Link
JP (1) JPS5262274A (https=)
AT (1) AT350583B (https=)
AU (1) AU508143B2 (https=)
BE (1) BE848108A (https=)
CA (1) CA1070316A (https=)
DE (1) DE2649546A1 (https=)
DK (1) DK503176A (https=)
ES (1) ES453263A1 (https=)
FI (1) FI763209A7 (https=)
FR (1) FR2331342A1 (https=)
GB (1) GB1573611A (https=)
HU (1) HU175667B (https=)
IE (1) IE44103B1 (https=)
IL (1) IL50748A0 (https=)
LU (1) LU76162A1 (https=)
NL (1) NL7611590A (https=)
NO (1) NO763812L (https=)
NZ (1) NZ182309A (https=)
PT (1) PT65759B (https=)
SE (1) SE7611405L (https=)
SU (1) SU634668A3 (https=)
ZA (1) ZA766201B (https=)

Also Published As

Publication number Publication date
FI763209A7 (https=) 1977-05-13
AT350583B (de) 1979-06-11
NO763812L (https=) 1977-05-13
HU175667B (hu) 1980-09-28
SE7611405L (sv) 1977-05-13
AU1890076A (en) 1978-04-27
BE848108A (fr) 1977-05-09
FR2331342A1 (fr) 1977-06-10
SU634668A3 (ru) 1978-11-25
GB1573611A (en) 1980-08-28
IE44103L (en) 1977-05-12
FR2331342B1 (https=) 1980-03-07
PT65759A (en) 1976-11-01
CA1070316A (en) 1980-01-22
DK503176A (da) 1977-05-13
JPS5262274A (en) 1977-05-23
IE44103B1 (en) 1981-08-12
ATA819776A (de) 1978-11-15
LU76162A1 (https=) 1977-05-18
NL7611590A (nl) 1977-05-16
IL50748A0 (en) 1976-12-31
PT65759B (en) 1978-04-27
ZA766201B (en) 1977-09-28
AU508143B2 (en) 1980-03-13
DE2649546A1 (de) 1977-05-26
NZ182309A (en) 1978-07-10

Similar Documents

Publication Publication Date Title
HUP9902121A2 (hu) Gonadotropin-leadó hormon antagonista hatású indolszármazékok és ezeket a vegyületeket tartalmazó gyógyszerkészítmények
CY1106522T1 (el) Ετepοκυκλικη ενωση και αντικαρκινικο μεσο που πepιεχει την ιδια ως δραστικο συστατικο
ES2104708T3 (es) Compuestos heterociclicos terapeuticos.
ES2043781T3 (es) Un procedimiento para la preparacion de nuevos derivados de 2beta-morfolino-androstano.
ES2137998T3 (es) Nuevos derivados de aminoacidos, procedimiento para su preparacion y composiciones farmaceuticas que contienen estos compuestos.
ES2053451T3 (es) Un procedimiento para la preparacion de un compuesto que tiene propiedades farmacologicas utiles.
CY1110979T1 (el) Παραγωγα κιναζολινης ως αναστολεις αγγειογενεσης και ενδιαμεσες ενωσεις αυτων
AR003453A1 (es) Inhibidores de agregado de plaquetas, su uso en la fabricacion de medicamentos, composicion farmaceutica que los contiene y procedimiento para la preparacion de dichos inhibidores
ES541521A0 (es) Un procedimiento para la preparacion de piridazinaminas.
UA39168C2 (uk) Фторалкоксифенільні похідні піперидину або хінуклідину, що є антагоністами речовини p і фармацевтична композиція на їх основі
ITRM20010356A1 (it) "5-alogeno derivati della triptamina utili come ligandi del recettore5-ht6 e/o 5-ht7 della serotonina.
ES2054872T3 (es) Nuevos derivados de acido bencimidazolin-2-oxo-1-carboxilico utiles como antagonistas de los receptores 5-ht.
AR028810A1 (es) Derivados de arilpiperazinil-ciclohexil indol, composiciones farmaceuticas que los comprenden y el uso de los mismos para la manufactura de medicamentos para el tratamiento de la depresion
AR003982A1 (es) Derivados de 11-(fenilo substituido)-estra-4,9-dieno), metodo de preparacion y uso del mismo, y una composicion farmaceutica que lo comprende
NO173998C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
UY26253A1 (es) Derivados del triazol y del imidazol
GT200000197A (es) 2-(3,5-bis-trifluorometil-fenil)-n-metil-n-(6- morfolin-4-il-4-o tolil-piridin-3-il)-isobutiramida.
PT97395A (pt) Processo para a preparacao de 2,9-di-substituidas-4h-pirido{1,2-a}-pirimidin-4-onas e de composicoes farmaceuticas que os contem
MX9305947A (es) Compuestos antagonistas del receptor 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que las contienen.
DK529888A (da) Substituerede n-(1-alkyl-3-hydroxy-4-piperidinyl) benzamider
MX9306311A (es) Compuestos antagonistas del receptor de 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
PH12022550436A1 (en) Alpha-d-galactopyranoside derivatives
TR199900732T2 (xx) PDE IV inhibe eden 2-siyanoiminoimidazol t�revleri.
IT1271456B (it) Composti pirrol-amidinici, e loro sali farmaceuticamente accettabili, processi di preparazione e composizioni farmaceutiche che li contengono
AR007352A1 (es) Derivados sustituidos de bencimidazol, proceso para su preparacion, formulacion farmaceutica que los contiene, y uso de dichos derivados para la manufactura de medicamentos